Managing Director at Truveta on a Mission to Save Lives With Data. Come Join Us! | Ex-Komodo Health Series B:E & IBM Watson Health | Focused on BD & Sales Partnerships With Pharma & Biotech Organizations
Great insights into the future of #weightloss #drugs #ozempic and GLP-1 with more competition from Eli Lilly and other manufacturers we can expect greater #access and #evidencegeneration demonstrating the long term #outcomes and #clinical benefits of these new medications that have taken the market by storm. Great insights from Scott Gottlieb below 👇#rwe #rwd
My @CNBC hit on new approval for Lilly’s GLP-1 for weight loss: Growing competition will advance clinical research into new benefits of this class of drugs and increase rebating in the category; ultimately expanding access and evidence generation for patients